Ar. Mensenkamp et al., Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver, J BIOL CHEM, 274(50), 1999, pp. 35711-35718
ApoE-deficient mice on low fat diet show hepatic triglyceride accumulation
and a reduced very low density lipoprotein (VLDL) triglyceride production r
ate. To establish the role of apoE in the regulation of hepatic VLDL produc
tion, the human APOE3 gene was introduced into apoE-deficient mice by cross
-breeding with APOE3 transgenics (APOE3/apoe-/- mice) or by adenoviral tran
sduction, APOE3 was expressed in the liver and, to a lesser extent, in brai
n, spleen, and lung of transgenic APOE3/apoe-/- mice similar to endogenous
apoe, Plasma cholesterol levels in APOE/apoe-/- mice (3.4 +/- 0.5 mM) were
reduced when compared with apoe-/- mice (12.6 +/- 1.4 mM) but still elevate
d when compared with wild type control values (1.9 +/- 0.1 mar). Hepatic tr
iglyceride accumulation in apoE-deficient mice was completely reversed by i
ntroduction of the APOE3 transgene, The in vivo hepatic VLDL-triglyceride p
roduction rate was reduced to 36% of control values in apoE-deficient mice
but normalized in APOE3/ apoe-/- mice. Hepatic secretion of apoB was not af
fected in either of the strains. Secretion of H-3-labeled triglycerides syn
thesized from [H-3]glycerol by cultured hepatocytes from apoE-deficient mic
e was four times lower than by APOE3/apoe-/- or control hepatocytes. The av
erage size of secreted VLDL particles produced by cultured apoE-deficient h
epatocytes was significantly reduced when compared with those of APOE3/ apo
e-/- and wild type mice. Hepatic expression of human APOE3 cDNA via adenovi
rus-mediated gene transfer in apoE-deficient mice resulted in a reduction o
f plasma cholesterol depending on plasma apoE3 levels. The in vivo VLDL-tri
glyceride production rate in these mice was increased up to 500% compared w
ith LacZ-injected controls and correlated with the amount of apoE3 per part
icle. These findings indicate a regulatory role of apoE in hepatic VLDL-tri
glyceride secretion, independent from its role in lipoprotein clearance.